Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: Ken W who wrote (3452)	10/24/2003 11:04:38 PM
From: Arthur Radley	Read Replies (1) \| Respond to of 23958

Ken, Actually there is a near term catalyst that should propel DSCO's shares higher. You might want to go back and read this June '03 PR announcing the top line results for Surfaxin. discoverylabs.com Within weeks, as the CEO mentioned on the Oct 02 CC, they will be releasing the final Phase III results and filing an NDA shortly after. Therefore we could see revenues for DSCO by late '04. Keep in mind this first filing is for a small indication (premature babies), however the mere approval for this condition should open the door for off-label use. Also, keep in mind that DSCO merely has to show equal efficacy to the gold standard Curosef, and the advantage will go to DSCO's product. The key to DSCO's product is that it isn't made from cows and pigs lungs that presents major manufacturing issues...for example, get consistency in a batch of the product production. Also, there is the safety issue of positive transfer of disease from the donor (pig or cow). DSCO will have the ability to have consistency in manufacturing, non-transfer of disease issue and cost of product advantage, so that is why a mere equal efficacy will make DSCO's product the gold standard. Again this first indication will bring small revenues, but will set the stage for bigger and better things IMO. Stay tune...or better yet, go to their website and listen to CC from early this month...might be worth the time and effort IMO. PS: Not that I normally listen to stock news letters, but this guy has a good track record and he has DSCO as one of his few picks...http://cbs.marketwatch.com/news/story.asp?guid=%7B9DDE34CC%2DB05F%2D4895%2DB8B9%2D71744C81F4B2%7D&siteid=mktw&